COMPASS PATHWAYS PLC Adjustments to Additional Paid in Capital, Warrant Issued
COMPASS PATHWAYS PLC (CMPS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $37.26 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-02-27
- COMPASS PATHWAYS PLC adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $687.00K.
- COMPASS PATHWAYS PLC adjustments to additional paid in capital, warrant issued for fiscal 2024 was $37.26M, a 5323.29% increase from fiscal 2023.
- COMPASS PATHWAYS PLC adjustments to additional paid in capital, warrant issued for fiscal 2023 was $687.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2024-12-31 | $37.26M 10-K · filed 2025-02-27 | |
| 2023-12-31 | $687.00K 10-K · filed 2025-02-27 | |
| 2023-06-30 | $687.00K 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |